Animal models for COVID-19

被引：594

作者：

Munoz-Fontela, Cesar ^{[1
,2
]}

Dowling, William E. ^{[3
]}

Funnell, Simon G. P. ^{[4
]}

Gsell, Pierre-S. ^{[5
]}

Riveros-Balta, A. Ximena ^{[5
]}

Albrecht, Randy A. ^{[6
]}

Andersen, Hanne ^{[7
]}

Baric, Ralph S. ^{[8
]}

Carroll, Miles W. ^{[4
]}

Cavaleri, Marco ^{[9
]}

Qin, Chuan ^{[10
]}

Crozier, Ian ^{[11
]}

Dallmeier, Kai ^{[12
]}

de Waal, Leon ^{[13
]}

de Wit, Emmie ^{[14
]}

Delang, Leen ^{[12
]}

Dohm, Erik ^{[15
]}

Duprex, W. Paul ^{[16
]}

Falzarano, Darryl ^{[17
]}

Finch, Courtney L. ^{[18
]}

Frieman, Matthew B. ^{[19
]}

Graham, Barney S. ^{[20
]}

Gralinski, Lisa E. ^{[8
]}

Guilfoyle, Kate ^{[13
]}

Haagmans, Bart L. ^{[21
]}

Hamilton, Geraldine A. ^{[22
]}

Hartman, Amy L. ^{[16
]}

Herfst, Sander ^{[21
]}

Kaptein, Suzanne J. F. ^{[12
]}

Klimstra, William B. ^{[23
]}

Knezevic, Ivana ^{[5
]}

Krause, Philip R. ^{[24
]}

Kuhn, Jens H. ^{[18
]}

Le Grand, Roger ^{[25
]}

Lewis, Mark G. ^{[7
]}

Liu, Wen-Chun ^{[6
]}

Maisonnasse, Pauline ^{[25
]}

McElroy, Anita K. ^{[26
]}

Munster, Vincent ^{[14
]}

Oreshkova, Nadia ^{[27
]}

Rasmussen, Angela L. ^{[28
]}

Rocha-Pereira, Joana ^{[12
]}

Rockx, Barry ^{[21
]}

Rodriguez, Estefania ^{[1
,2
]}

Rogers, Thomas F. ^{[29
]}

Salguero, Francisco J. ^{[4
]}

Schotsaert, Michael ^{[6
]}

Stittelaar, Koert J. ^{[13
]}

Jan Thibaut, Hendrik ^{[12
]}

Tseng, Chien-Te ^{[30
]}

机构：

[1] Bernhard Nocht Inst Trop Med, Hamburg, Germany

[2] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany

[3] Ctr Epidem Preparedness Innovat CEPI, Washington, DC USA

[4] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England

[5] WHO, Geneva, Switzerland

[6] Icahn Sch Med Mt Sinai, Dept Microbiol, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA

[7] Bioqual Inc, Rockville, MD USA

[8] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA

[9] European Med Agcy, Amsterdam, Netherlands

[10] Chinese Acad Med Sci & Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China

[11] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD USA

[12] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[13] Viroclin Xplore, Schaijk, Netherlands

[14] NIAID, Lab Virol, NIH, Hamilton, MT USA

[15] Univ Alabama Birmingham, Anim Resources Program, Birmingham, AL USA

[16] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA

[17] Univ Saskatchewan, VIDO Intervac, Saskatoon, SK, Canada

[18] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA

[19] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA

[20] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[21] Erasmus MC, Dept Virosci, Rotterdam, Netherlands

[22] Emulate Inc, Boston, MA USA

[23] Univ Pittsburgh, Dept Immunol, Ctr Vaccine Res, Pittsburgh, PA USA

[24] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA

[25] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, INSERM, CEA, Paris, France

[26] Univ Pittsburgh, Sch Med, Div Pediat Infect Dis, Ctr Vaccine Res, Pittsburgh, PA USA

[27] Wageningen Univ & Res, Wageningen Biovet Res WBVR, Lelystad, Netherlands

[28] Columbia Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA

[29] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA

[30] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA

[31] Campus Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, IRTA UAB, Bellaterra, Spain

[32] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany

[33] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Carol Yu Ctr Infect, Hong Kong, Peoples R China

[34] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA

[35] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA

[36] Tulane Natl Primate Res Ctr, Covington, LA USA

[37] UAB, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain

[38] CSIRO, Australian Ctr Dis Preparedness, Geelong, Vic, Australia

[39] Univ York, Dept Hlth Sci, York, N Yorkshire, England

[40] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

RESPIRATORY SYNDROME CORONAVIRUS; MOUSE MODEL; SARS; INFECTION; MICE; SARS-COV-2; MERS; PATHOGENESIS; RESERVOIRS; EFFICACY;

D O I：

10.1038/s41586-020-2787-6

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.

引用

页码：509 / 515

页数：7

共 50 条

[31] How the COVID-19 pandemic highlights the necessity of animal research
Genzel, Lisa
Adan, Roger
Berns, Anton
van den Beucken, Jeroen
Blokland, Arjan
Boddeke, Erik H. W. G. M.
Bogers, Willy M.
Bontrop, Ronald
Bulthuis, R.
Bousema, Teun
Clevers, Hans
Coenen, Tineke C. J. J.
van Dam, Anne-Marie
Deen, Peter M. T.
van Dijk, K. W.
Eggen, Bart J. L.
Elgersma, Ype
Erdogan, Izel
Englitz, Bernard
van Vlissingen, J. Martje Fentener
la Fleur, Susanne
Fouchier, Ron
Fitzsimons, Carlos P.
Frieling, Wilbert
Haagmans, Bart
Heesters, Balthasar A.
Henckens, Marloes
Herfst, Sander
Hol, Elly
van den Hove, Daniel
de Jonge, Marien I.
Jonkers, Jos
Joosten, Leo A. B.
Kalsbeek, Andries
Kamermans, Maarten
Kampinga, Harm H.
Kas, Martien J.
Keijer, J.
Kersten, Sander
Kiliaan, Amanda J.
Kooij, Taco W. A.
Kooijman, Sander
Koopman, Werner J. H.
Korosi, Aniko
Krugers, Harm J.
Kuiken, Thijs
Kushner, Steven A.
Langermans, Jan A. M.
Lesscher, Heidi
Lucassen, Paul J.
CURRENT BIOLOGY, 2020, 30 (18) : R1014 - R1018
[32] Defining protective epitopes for COVID-19 vaccination models
Cimolai, Nevio
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1772 - 1773
[33] COVID-19 in Human, Animal, and Environment: A Review
Swelum, Ayman A.
Shafi, Manal E.
Albaqami, Najah M.
El-Saadony, Mohamed T.
Elsify, Ahmed
Abdo, Mohamed
Taha, Ayman E.
Abdel-Moneim, Abdel-Moneim E.
Al-Gabri, Naif A.
Almaiman, Amer A.
Saleh Al-wajeeh, Abdullah
Tufarelli, Vincenzo
Staffa, Vito N.
Abd El-Hack, Mohamed E.
FRONTIERS IN VETERINARY SCIENCE, 2020, 7
[34] Animal Transmission of SARS-CoV-2 and the Welfare of Animals during the COVID-19 Pandemic
Ekstrand, Kimberly
Flanagan, Amanda J.
Lin, Ilyan E.
Vejseli, Brendon
Cole, Allicyn
Lally, Anna P.
Morris, Robert L.
Morgan, Kathleen N.
ANIMALS, 2021, 11 (07):
[35] Potential neurological manifestations of COVID-19: a narrative review
Pergolizzi, Joseph V., Jr.
Raffa, Robert B.
Varrassi, Giustino
Magnusson, Peter
LeQuang, Jo Ann
Paladini, Antonella
Taylor, Robert
Wollmuth, Charles
Breve, Frank
Chopra, Maninder
Nalamasu, Rohit
Christo, Paul J.
POSTGRADUATE MEDICINE, 2022, 134 (04) : 395 - 405
[36] Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig
Heegaard, Peter M. H.
Sturek, Michael
Alloosh, Mouhamad
Belsham, Graham J.
FRONTIERS IN MICROBIOLOGY, 2020, 11
[37] Generalized myoclonus in COVID-19
Rabano-Suarez, Pablo
Bermejo-Guerrero, Laura
Mendez-Guerrero, Antonio
Parra-Serrano, Javier
Toledo-Alfocea, Daniel
Sanchez-Tejerina, Daniel
Santos-Fernandez, Teresa
Dolores Folgueira-Lopez, Maria
Gutierrez-Gutierrez, Judit
Ayuso-Garcia, Blanca
Gonzalez de la Aleja, Jesus
Benito-Leon, Julian
NEUROLOGY, 2020, 95 (06) : E767 - E772
[38] COVID-19: An overview for dermatologists
Sanghvi, Akanksha R.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (12) : 1437 - 1449
[39] COVID-19: Where is the treatment?
Sabeerabi, Bonala
Vemula, Sarojamma
Vadde, Ramakrishna
Nagaraju, Ganji Purnachandra
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (05): : 309 - 322
[40] Susceptibility to SARS, MERS, and COVID-19 from animal health perspective
Gautam, Aasish
Kaphle, Krishna
Shrestha, Birendra
Phuyal, Samiksha
OPEN VETERINARY JOURNAL, 2020, 10 (02) : 164 - 177

← 1 2 3 4 5 →